Literature DB >> 1547470

The usefulness of the Western Aphasia Battery for differential diagnosis of Alzheimer dementia and focal stroke syndromes: preliminary evidence.

J Horner1, D V Dawson, A Heyman, A M Fish.   

Abstract

We assessed the usefulness of the Western Aphasia Battery for distinguishing the language disturbances caused by Alzheimer dementia (AD) from those caused by stroke. Using discriminant function analyses, the multiple variable "aphasia quotient--reading quotient--writing quotient" classified 29 (72.5%) of the 40 patients correctly. These 29 patients included 8 of 10 patients with left hemisphere infarction and fluent aphasia; 6 of 10 with AD; 5 of 10 patients with right hemisphere infarction; and all 10 of the neurologically normal control subjects. The patients with AD and those with right hemisphere stroke were the most difficult to classify using the aphasia battery.

Entities:  

Mesh:

Year:  1992        PMID: 1547470     DOI: 10.1016/0093-934x(92)90057-l

Source DB:  PubMed          Journal:  Brain Lang        ISSN: 0093-934X            Impact factor:   2.381


  4 in total

Review 1.  Alzheimer's disease. Physician-patient communication.

Authors:  J B Orange; D W Molloy; J A Lever; P Darzins; C R Ganesan
Journal:  Can Fam Physician       Date:  1994-06       Impact factor: 3.275

2.  Statistical mapping analysis of brain metabolism in patients with subcortical aphasia after intracerebral hemorrhage: a pilot study of F-18 FDG PET images.

Authors:  Yong Wook Kim; Hyoung Seop Kim; Young-Sil An
Journal:  Yonsei Med J       Date:  2012-01       Impact factor: 2.759

3.  Western Aphasia Battery-Revised Profiles in Primary Progressive Aphasia and Primary Progressive Apraxia of Speech.

Authors:  Heather M Clark; Rene L Utianski; Joseph R Duffy; Edythe A Strand; Hugo Botha; Keith A Josephs; Jennifer L Whitwell
Journal:  Am J Speech Lang Pathol       Date:  2019-10-22       Impact factor: 2.408

4.  Nao-Xue-Shu Oral Liquid Improves Aphasia of Mixed Stroke.

Authors:  Yuping Yan; Mingzhe Wang; Liang Zhang; Zhenwei Qiu; Wenfei Jiang; Men Xu; Weidong Pan; Xiangjun Chen
Journal:  Evid Based Complement Alternat Med       Date:  2015-10-19       Impact factor: 2.629

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.